Ludbrook P A, Rentrop P
Cardiol Clin. 1987 Feb;5(1):79-90.
Because there are several means by which a clinician may pharmacologically activate the fibrinolytic system for thrombolysis, the clinician must understand the clinical ramifications of the use of each pharmacologic agent. Intracoronary streptokinase is one such agent whose therapeutic use, although effective in many cases, must not be taken lightly. This article, therefore, reviews the pharmacology, therapeutic uses, and possible complications that could arise as a result of intracoronary streptokinase.
由于临床医生可通过多种药理学方法激活纤维蛋白溶解系统以进行溶栓治疗，因此临床医生必须了解每种药物使用的临床后果。冠状动脉内注射链激酶就是这样一种药物，其治疗用途虽然在许多情况下有效，但绝不能掉以轻心。因此，本文回顾了冠状动脉内注射链激酶的药理学、治疗用途以及可能出现的并发症。
